Niki BioSolutions, Inc. (NIKI) — Cash Flow-to-Debt Ratio
Niki BioSolutions, Inc. (NIKI) has a Cash Flow-to-Debt Ratio of -0.11x as of December 2025, meaning its operating cash flow of $-535.25K could theoretically repay 0% of its total liabilities ($4.90 Million) in one year. For the full cash flow conversion analysis, see Niki BioSolutions, Inc. (NIKI) cash flow conversion.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Niki BioSolutions, Inc. Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Niki BioSolutions, Inc. across 9 annual periods. See NIKI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Annual Cash Flow-to-Debt Ratio for Niki BioSolutions, Inc. (2017–2025)
Year-by-year debt coverage analysis for Niki BioSolutions, Inc.. Check cash flow quality index of Niki BioSolutions, Inc. to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.37x | $-1.84 Million | $4.90 Million | ▼ -37.1% |
| 2024 | -0.27x | $-1.19 Million | $4.35 Million | ▲ +81.4% |
| 2023 | -1.47x | $-7.72 Million | $5.26 Million | ▼ -55.5% |
| 2022 | -0.95x | $-12.32 Million | $13.03 Million | ▲ +71.6% |
| 2021 | -3.33x | $-14.65 Million | $4.40 Million | ▼ -27.0% |
| 2020 | -2.62x | $-15.93 Million | $6.08 Million | ▼ -78.3% |
| 2019 | -1.47x | $-13.38 Million | $9.10 Million | ▼ -80.6% |
| 2018 | -0.81x | $-10.04 Million | $12.33 Million | ▲ +81.3% |
| 2017 | -4.35x | $-5.78 Million | $1.33 Million | — |